You have 9 free searches left this month | to do more
Showing 1 - 25 of
250 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Cologne, Germany
    University of Cologne
2021-08-17
Aug 17, 2021
M
Recruiting
  • Lupus Nephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-05-19
May 19, 2021
W
Not yet recruiting
  • Glioblastoma
  • Daratumumab
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
2021-06-25
Jun 25, 2021
M
Recruiting
  • Alzheimer Disease
  • Daratumumab Injection
  • Manhasset, New York
    The Litwin-Zucker Research Center
2021-11-16
Nov 16, 2021
D
Not yet recruiting
  • Hemolytic Anemia
  • Daratumumab / Hyaluronidase Injection
  • (no location specified)
2021-10-13
Oct 13, 2021
U
Recruiting
  • POEMS Syndrome
  • Daratumumab Injection
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
2021-08-02
Aug 2, 2021
A
Not yet recruiting
  • Multiple Myeloma
  • Lenalidomide Pill
  • +2 more
  • (no location specified)
2021-06-02
Jun 2, 2021
A
Not yet recruiting
  • Plasma Cell Leukemia
  • Daratumumab
  • (no location specified)
2021-09-22
Sep 22, 2021
P
Recruiting
  • Amyloidosis; Systemic
  • Daratumumab
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
2021-05-31
May 31, 2021
S
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-10-05
Oct 5, 2021
J
Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-09-07
Sep 7, 2021
M
Recruiting
  • Multiple Myeloma
  • Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-10-01
Oct 1, 2021
B
Completed
  • AL Amyloidosis
  • daratumumab
  • Boston, Massachusetts
    Boston Medical Center
2021-04-15
Apr 15, 2021
I
Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
2021-06-23
Jun 23, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Part 1 (Dose Escalation): Daratumumab
  • +3 more
  • Boston, Massachusetts
  • +7 more
2021-11-04
Nov 4, 2021
F
Completed
  • Membranoproliferative Glomerulonephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic
2021-06-28
Jun 28, 2021
C
Active, not recruiting
  • Multiple Myeloma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2021-11-01
Nov 1, 2021
H
Recruiting
  • Multiple Myeloma
  • Daratumumab Injection
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer & Research Institute
2021-10-11
Oct 11, 2021
M
Suspended
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2021-09-27
Sep 27, 2021
R
Withdrawn
  • Allosensitization
  • Heart Transplant Failure and Rejection
  • Daratumumab
  • (no location specified)
2020-10-26
Oct 26, 2020
W
Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021
W
Recruiting
  • Amyloid
  • +2 more
  • Daratumumab
  • +2 more
  • Palo Alto, California
  • +3 more
2021-06-23
Jun 23, 2021
O
Recruiting
  • ITP
  • Daratumumab Injection
  • Odense, Denmark
  • +5 more
2021-08-24
Aug 24, 2021